{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/67919-030#drug","name":"ZERBAXA","alternateName":"ceftolozane and tazobactam","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"67919-030"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA206829"},{"@type":"PropertyValue","propertyID":"UNII","value":"7R247U84HY|UXA545ABTT"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"70ac1d90-eff3-4f0b-9f46-5846c571b32f"}],"activeIngredient":"CEFTOLOZANE SULFATE, TAZOBACTAM SODIUM","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Merck Sharp & Dohme LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA206829","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70ac1d90-eff3-4f0b-9f46-5846c571b32f","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67919-030"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T20:40:58.459Z"}}